Laser-Triggered Nanobiomaterials for Inhibiting Tumor Growth
暫譯: 激光觸發的奈米生物材料抑制腫瘤生長

Professor Maoquan Chu received his PhD in Chemical Engineering from East China University of Science and Technology in 2001. He then conducted his postdoctoral work in the School of Life Science and Technology, Shanghai Jiaotong University, China. At this stage, he delved into biomaterials and nanotechnology. In 2004, he joined the School of Life Science and Technology, Tongji University, China. In 2007, he won the China Education Ministry's "New Century Excellent Talents Supporting Plan." In 2008, he was hired as a professor and PhD supervisor. He is now a principal investigator in the School of Life Science and Technology, Tongji University and in the Research Center for Translational Medicine, Shanghai East Hospital, China. His main area of research is nanobiomedicine, with a current focus on cancer therapy using nanobiomaterials. His recent research has been published in related journals such as Biomaterials, Acta Biomaterialia, Nano Research, Theranostics, etc. He has also published three books about biomaterials.

教授朱毛泉於2001年在華東理工大學獲得化學工程博士學位。隨後，他在中國上海交通大學生命科學與技術學院進行博士後研究。在這個階段，他深入研究生物材料和納米技術。2004年，他加入中國同濟大學生命科學與技術學院。2007年，他獲得中國教育部的「新世紀優秀人才支持計畫」。2008年，他被聘為教授及博士生導師。目前，他是同濟大學生命科學與技術學院的主要研究員，以及中國上海東方醫院轉化醫學研究中心的研究員。他的主要研究領域是納米生物醫學，當前專注於使用納米生物材料進行癌症治療。他最近的研究已發表在相關期刊上，如《Biomaterials》、《Acta Biomaterialia》、《Nano Research》、《Theranostics》等。他還出版了三本有關生物材料的書籍。